Dolutegravir



Dolutegravir





(do loot ah grah veer)

Tivicay

PREGNANCY CATEGORY B


Drug Classes

Antiviral

Integrase inhibitor


Therapeutic Actions

Antiviral, inhibits the virus-specific enzyme intergase, an encoded enzyme needed for viral replication, preventing formation of HIV-a provirus, which leads to decreased viral load and increased active CD4 cells.


Indications



  • Treatment of HIV-1 infection in adults and children 12 yr and older in combination with other antiretroviral agents




Available Forms

Tablets—50 mg


Dosages

Adults and children 12 yr and older, weighing at least 40 kg

50 mg/day PO; when taken with efavirenz, fosamprenavir/ritonavir, tipranavir/ritonavir, rifampin–50 mg PO bid; with suspected resistance–50 mg PO bid


Pharmacokinetics















Route Onset Peak
Oral Rapid 2–3 hr

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 20, 2016 | Posted by in NURSING | Comments Off on Dolutegravir

Full access? Get Clinical Tree

Get Clinical Tree app for offline access